U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 18:26:16 GMT 2023
Edited
by admin
on Sat Dec 16 18:26:16 GMT 2023
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type
Sequence Type COMPLETE
Record UNII
8MSM5N7RMK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Givastomig
INN  
Official Name English
givastomig [INN]
Common Name English
Immunoglobulin G1 [300-alanine], anti-(claudin CLDN18.2) (human-Mus musculus γ1-chain) fusion protein with peptide linker ((GGGGS)3) fusion protein with immunoglobulin anti-(tumor necrosis factor receptor TNFRSF9) (human-Mus musculus single-chain variab
Common Name English
Immunoglobulin G1-scFv_L-kappa, anti-[Homo sapiens CLDN18 (claudin 18, claudin-18, SFTPJ, surfactant associated protein J)isoform 2, extracellular domain 1 (EC1)], anti-[Homo sapiens TNFRSF9 (TNF receptor superfamily member 9, 4-1BB, T cell antigen ILA,
Common Name English
Fused G1-scFv lambda-heavy chain humanized (1-716) [gamma1 heavy chain anti-CLDN18 humanized (1-450) [VH (Homo sapiens IGHV1-3*01 (85.7%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120)-Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1,
Common Name English
Code System Code Type Description
INN
12650
Created by admin on Sat Dec 16 18:26:16 GMT 2023 , Edited by admin on Sat Dec 16 18:26:16 GMT 2023
PRIMARY
FDA UNII
8MSM5N7RMK
Created by admin on Sat Dec 16 18:26:16 GMT 2023 , Edited by admin on Sat Dec 16 18:26:16 GMT 2023
PRIMARY
CAS
2762499-30-7
Created by admin on Sat Dec 16 18:26:16 GMT 2023 , Edited by admin on Sat Dec 16 18:26:16 GMT 2023
PRIMARY
From To
4_140 4_200
4_23 4_94
3_140 3_200
3_23 3_94
2_617 2_691
2_568 2_639
2_487 2_554
2_370 2_428
2_264 2_324
2_223 4_220
2_147 2_203
2_22 2_96
1_617 1_691
1_568 1_639
1_487 1_554
1_370 1_428
1_264 1_324
1_232 2_232
1_229 2_229
1_223 3_220
1_147 1_203
1_22 1_96
Related Record Type Details
TARGET -> ACTIVATOR
Pre-clinical
TARGET->LIGAND
Pre-clinical
Related Record Type Details
ACTIVE MOIETY
TJ033721 is designed to promote 4-1BB clustering by bridging T cells with CLDN18.2-positive tumor cells
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL